Multiple Sclerosis Discovery Forum
Awareness …. It’s the buzz word for the month of March and MS. I’m taking a different approach for MS Awareness and offering additional information and resources the MS community may not be aware of as well. My list of hidden gems definitely includes the Multiple Sclerosis Discovery Forum. Are you aware of this group and the valuable services they provide to doctors, researchers and anyone else interested in keeping current on MS research news? The MS Discovery Forum is a unique and valuable resource that shares the latest MS projects, monitors the MS drug pipeline, and offers a forum where researchers, clinicians and people with an interest in MS can share and learn from each other.
You may have read from me or one of the other writers here that the multiple sclerosis research field is expanding at an unbelievable rate, it is a challenge to stay current on this changes, and the MS Discovery Forum offers the proof to back up that claim. They publish a weekly list of the MS related peer reviewed research papers that have been added to the world of MS knowledge the previous week. This is one of the simplest ways to stay aware of the latest and greatest MS research news. The week of February 27 – March 6 offers links to 65 new papers, and here are just a few of the titles of wide ranging and newly released research:
- Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
- Respiratory dysfunction in multiple sclerosis.
- Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
- Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis.
- Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
- The harm of ham hocks: Foreign body impaction in long-standing multiple sclerosis.
- Control of IL-17 receptor signaling and tissue inflammation by the p38α-MKP-1 signaling axis in a mouse model of multiple sclerosis.
No, I did not make up any of these titles, especially the one about the harm of ham hocks, which is not yet available to read on line. I am particularly interested in reading the March issue of the Ear, Nose, Throat Journal, to learn more about this hazard. It would take me hours of research to find these titles on my own. The list for the previous week included titles for 45 newly published articles.
The MS Discovery Forum’s Drug Development Pipeline is one of the most straightforward ways to track what new MS drugs are being looked at in laboratories and clinical trials. They note they are aware of 100+ different drugs being looked at for MS and are working as fast as they can with their limited resources to get them into their database. For now, they have comprehensive information on 44 drugs that are in development but not yet available to those of us with MS.
There are many other wonderful gems to be aware of on this website – the research roundup news, a visualization of what researchers in the world are influencing Phase III clinical trials, MS podcasts, blogs, and professional resources (conferences, job ads, etc.). The MS Discovery Forum is a part of the Accelerated Cure Project, and I am actively involved with their iConquerMS™ patient powered research network, where we are developing our own patient directed MS research. (please click on the link to learn more and join this important project).
If you want to know more about what is being done to find a cure, a better treatment, or ways that our quality of life may be improved, check out the Multiple Sclerosis Discovery Forum. You will be amazed at the work on MS behind the scenes that we are not necessarily aware of being done.
Wishing you well,
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.